Results 291 to 300 of about 7,109,986 (349)

Socioeconomic Health Disparities in the Treatment of Thyroid Cancer: A Single Institution in Southwestern Ohio

Head &Neck, EarlyView.
ABSTRACT Background Disparities in thyroid cancer care are driven by demographic and socioeconomic factors such as insurance status, income, and access to specialized care. Methods Retrospective chart review. Demographic and clinical data from 281 adult patients who underwent thyroidectomy or hemithyroidectomy for papillary or follicular thyroid cancer
Breanna Dominguez, Aurora Moberly, Nga Tran, Timothy Crawford, Sameep Kadakia, Mac Kenzie Reece   +5 more
wiley   +1 more source

Comparative Use of Double Bipolar Forceps Versus Ultrasound Energy Device in Transoral Robotic Thyroidectomy

Head &Neck, EarlyView.
ABSTRACT Purpose Transoral robotic thyroidectomy (TORT) offers excellent cosmetic outcomes and safe access to the central neck without a cervical incision. Traditionally, ultrasonic energy devices have been used for dissection and hemostasis, though these instruments are limited by unilateral use, bulkiness, and greater thermal spread.
Moon Young Oh, Mustafa AlMadan, Dawon Park, Kwangsoon Kim, Young Jun Chai, Hoon Yub Kim   +5 more
wiley   +1 more source

Somatic cell reprogramming for Parkinson's disease treatment

Ibrain, Volume 11, Issue 1, Page 59-73, Spring 2025.
The fundamental purpose of cell reprogramming to treat Parkinson's disease is to generate dopaminergic neurons (DAN) and do transplantation. There are two ways to accomplish this. One method is to induce cells into induced DA neurons (iDAN) directly or to induce cells into induced pluripotent stem cells and ultimately into iDAN in vitro. Another option
Xiaozhuo Li, Kevin Fang, Fengping Wang
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The role of gonadotropins in the follicular phase

Annals of the New York Academy of Sciences, 2010
Folliculogenesis in humans is a lengthy process that involves several regulators. Pituitary gonadotropins play crucial roles in the late stages, particularly in the last 15 days of follicle maturation. During the intercycle rise of follicle‐stimulating hormone (FSH), selection of the dominant follicle takes place.
Ioannis E, Messinis, Christina I, Messini, Konstantinos, Dafopoulos   +2 more
openaire   +3 more sources

Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study.

Lancet Oncology, The, 2022
L. Budde, L. Sehn, M. Matasar, S. Schuster, S. Assouline, P. Giri, J. Kuruvilla, M. Canales, S. Dietrich, K. Fay, M. Ku, L. Nastoupil, C. Cheah, M. Wei, S. Yin, Chi-Chung Li, Huang Huang, A. Kwan, E. Penuel, N. Bartlett   +19 more
semanticscholar   +3 more sources

Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial

Nature Medicine, 2021
N. Fowler, M. Dickinson, M. Dreyling, J. Martínez-López, A. Kolstad, J. Butler, M. Ghosh, L. Popplewell, J. Chavez, E. Bachy, Koji Kato, H. Harigae, M. Kersten, C. Andreadis, P. Riedell, P. Ho, J. Pérez-Simón, Andy I. Chen, L. Nastoupil, B. von Tresckow, A. Ferreri, T. Teshima, P. Patten, J. Mcguirk, A. Petzer, F. Offner, A. Viardot, P. Zinzani, R. Malladi, A. Zia, R. Awasthi, Aisha Masood, O. Anak, S. Schuster, C. Thieblemont   +34 more
semanticscholar   +3 more sources

Physiology of Follicular Phase

2015
Ubaldi F, Cimadomo D, Capalbo A, Rienzi L   +3 more
openaire   +2 more sources

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.

Lancet, The, 2011
G. Salles, J. Seymour, F. Offner, A. López-Guillermo, D. Belada, L. Xerri, P. Feugier, R. Bouabdallah, J. Catalano, P. Brice, D. Caballero, C. Haioun, L. Pedersen, A. Delmer, D. Simpson, S. Leppa, P. Soubeyran, A. Hagenbeek, O. Casasnovas, T. Intragumtornchai, C. Fermé, Maria Gomes da Silva, C. Sebban, A. Lister, J. Estell, G. Milone, A. Sonet, M. Mendila, B. Coiffier, H. Tilly   +29 more
semanticscholar   +3 more sources

Follicular phase treatment of luteal phase dysfunction

Fertility and Sterility, 1981
Previously, we demonstrated that selective suppression of serum follicle-stimulating hormone (FSH) in monkeys treated with charcoal-extracted porcine follicular fluid (pFF) in the early follicular phase induced luteal defects resembling those which occur spontaneously in women and monkeys.
G S, Dizerega, G D, Hodgen
openaire   +2 more sources

GnRH antagonist versus follicular-phase single-dose GnRH agonist protocol in patients of normal ovarian responses during controlled ovarian stimulation

Gynecological Endocrinology, 2018
Objective: This study aims to explore the differences of the ovarian stimulation (OS) characteristics, laboratory, and clinical outcomes between follicular-phase single-dose gonadotropin-releasing hormone (GnRH) agonist protocol and GnRH antagonist ...
Yudi Geng, Y. Xun, Shiqiao Hu, Q. Lai, Lei Jin   +4 more
semanticscholar   +1 more source